
    
      Two groups will be prepared then decision of which one take curcumin paste will be selected
      according to randomized numbers in a sequentially numbered, opaque, sealed envelope

      1 group will take topical corticosteroid and 1 will take curcumin paste then IL-33 level in
      saliva will be measured at the base line and at the end of 4th week pain and clinical
      parameters will be measured at 2nd and 4th week
    
  